lncRNA MALAT1 contributes to neuropathic pain development through regulating miR-129-5p/HMGB1 axis in a rat model of chronic constriction injury

References

• Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–819.
   PubMed Web of Science ®Google Scholar
• Gierthmuhlen J, Baron R. Neuropathic pain. Semin Neurol. 2016;36:462–468.
   PubMed Web of Science ®Google Scholar
• Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635.
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Overcoming obstacles to developing new analgesics. Nat Med. 2010;16(11):1241–1247.
   PubMed Web of Science ®Google Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361.
   PubMed Web of Science ®Google Scholar
• Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010;1338:20–35.
   PubMed Web of Science ®Google Scholar
• Pang KC, Dinger ME, Mercer TR, et al. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J Immunol. 2009;182(12):7738–7748.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Qureshi IA, Gokhan S, et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci. 2010;11(1):14.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Sunkin SM, et al. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA. 2008;105(2):716–721.
   PubMed Web of Science ®Google Scholar
• Kazemzadeh M, Safaralizadeh R, Orang AV. LncRNAs: emerging players in gene regulation and disease pathogenesis. J Genet. 2015;94(4):771–784.
   PubMed Web of Science ®Google Scholar
• Tang S, Zhou J, Jing H, et al. Functional roles of lncRNAs and its potential mechanisms in neuropathic pain. Clin Epigenetics. 2019;11:78.
   PubMed Web of Science ®Google Scholar
• Hu JZ, Rong ZJ, Li M, et al. Silencing of lncRNA PKIA-AS1 attenuates spinal nerve ligation-induced neuropathic pain through epigenetic downregulation of CDK6 expression. Front Cell Neurosci. 2019;13:50.
   PubMed Web of Science ®Google Scholar
• Peng H, Zou L, Xie J, et al. lncRNA NONRATT021972 siRNA decreases diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia. Mol Neurobiol. 2017;54(1):511–523.
   PubMed Web of Science ®Google Scholar
• Meng C, Yang X, Liu Y, et al. Decreased expression of lncRNA Malat1 in rat spinal cord contributes to neuropathic pain by increasing neuron excitability after brachial plexus avulsion. JPR. 2019;12:1297–1310.
   Web of Science ®Google Scholar
• Chen ZL, Liu JY, Wang F, et al. Suppression of MALAT1 ameliorates chronic constriction injury-induced neuropathic pain in rats via modulating miR-206 and ZEB2. J Cell Physiol. 2019;234:15647–15653.
   PubMed Web of Science ®Google Scholar
• Storkson RV, Kjorsvik A, Tjolsen A, et al. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods. 1996;65:167–172.
   PubMed Web of Science ®Google Scholar
• Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med. 2017;377(25):2465–2473.
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107.
   PubMed Web of Science ®Google Scholar
• Bertozzi MM, Rossaneis AC, Fattori V, et al. Diosmin reduces chronic constriction injury-induced neuropathic pain in mice. Chem Biol Interact. 2017;273:180–189.
   PubMed Web of Science ®Google Scholar
• Baron R, Likar R, Martin-Mola E, et al. Effectiveness of tapentadol prolonged release (PR) compared with oxycodone/naloxone PR for the management of severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, phase 3b/4 study. Pain Pract. 2016;16(5):580–599.
   PubMed Web of Science ®Google Scholar
• Wu Q, Meng WY, Jie Y, et al. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol. 2018;233(9):6750–6757.
   PubMed Web of Science ®Google Scholar
• Liu K, Huang J, Ni J, et al. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle. 2017;16(6):578–587.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X, Piao C, et al. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Biomed Pharmacother. 2019;118:109079.
   PubMed Web of Science ®Google Scholar
• Zhuo W, Liu Y, Li S, et al. Long Noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS. Gastroenterology. 2019;156(3):676–691 e11.
   PubMed Web of Science ®Google Scholar
• Xu Z, Xi K. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis. Biomed Pharmacother. 2019;118:109222.
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076.
   PubMed Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041.
   PubMed Web of Science ®Google Scholar
• Ji Q, Liu X, Fu X, et al. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway. PLoS One. 2013;8(11):e78700.
   PubMed Web of Science ®Google Scholar
• Lin N, Yao Z, Xu M, et al. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells. J Exp Clin Cancer Res. 2019;38(1):244.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Q, Zhang J, et al. Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell Biosci. 2017;7(1):19.
   PubMed Web of Science ®Google Scholar
• Ma P, Li Y, Zhang W, et al. Long non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation while Stimulates Neurite Outgrowth and its Correlation with MiR-125b Mediated PTGS2, CDK5 and FOXQ1 in Alzheimer’s disease. Curr Alzheimer Res. 2019;16:596–612.
   PubMed Web of Science ®Google Scholar
• Wan W, Cao L, Khanabdali R, et al. The emerging role of HMGB1 in neuropathic pain: a potential therapeutic target for neuroinflammation. J Immunol Res. 2016;2016:1–9.
   Web of Science ®Google Scholar
• Feldman P, Due MR, Ripsch MS, et al. The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J Neuroinflammation. 2012;9(1):180.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014;114(9):1377–1388.
   PubMed Web of Science ®Google Scholar
• Xia LX, Ke C, Lu JM. NEAT1 contributes to neuropathic pain development through targeting miR-381/HMGB1 axis in CCI rat models. J Cell Physiol. 2018;233(9):7103–7111.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Li Y, Zhou Z, et al. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Biomed Pharmacother. 2017;95:922–928.
   PubMed Web of Science ®Google Scholar